Loading...
Loading...
In a report published Monday, Deutsche Bank analyst Eric Katzman downgraded the rating on
Mead Johnson NutritionMJN from Buy to Hold, but reiterated the $103.00 price target.
In the report, Deutsche Bank noted, “With recent headlines pointing to Danone's interest in Mead Johnson as a potential M&A target (Reuters, 10/17/14) and the latter's stock now up close to 20% for 2014, we believe the time is right to downgrade the shares. Given current valuation (25x P/E, 17x EBITDA), we adjust our fundamental-based opinion on Mead to HOLD from BUY, maintaining our $103 target, and removing the stock as our 2014 ‘Top Pick'.”
Mead Johnson Nutrition closed on Friday at $100.23.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in